XML 37 R21.htm IDEA: XBRL DOCUMENT
v3.23.4

INCOME TAXES | 12 Months Ended
--- | ---
Oct. 31, 2023
Income Tax Disclosure [Abstract] |
Income Tax Disclosure [Text Block] | INCOME TAXES The components of income before income taxes and noncontrolling interests are as follows (in thousands):
| Year ended October 31,
| 2023 |  | 2022 |  | 2021
Domestic | $479,990 |  |  | $429,329 |  |  | $345,733 |
Foreign | 75,293 |  |  | 61,694 |  |  | 41,325 |
Income before taxes and noncontrolling interests | $555,283 |  |  | $491,023 |  |  | $387,058 |
The components of the provision for income taxes on income before income taxes and noncontrolling interests are as follows (in thousands):
| Year ended October 31,
| 2023 |  | 2022 |  | 2021
Current: |  |  |  |  |
Federal | $96,492 |  |  | $63,861 |  |  | $47,839 |
State | 18,225 |  |  | 13,015 |  |  | 11,639 |
Foreign | 22,714 |  |  | 14,648 |  |  | 13,457 |
| 137,431 |  |  | 91,524 |  |  | 72,935 |
Deferred: |  |  |  |  |
Federal | (19,049) |  |  | 8,154 |  |  | (10,097) |
State | (4,311) |  |  | 1,129 |  |  | (3,251) |
Foreign | (3,171) |  |  | (407) |  |  | (2,287) |
| (26,531) |  |  | 8,876 |  |  | (15,635) |
Total income tax expense | $110,900 |  |  | $100,400 |  |  | $57,300 |
A reconciliation of the federal statutory income tax rate to the Company’s effective tax rate is as follows:
| Year ended October 31,
| 2023 |  | 2022 |  | 2021
Federal statutory income tax rate | 21.0 | % |  | 21.0 | % |  | 21.0 | %
State taxes, net of federal income tax benefit | 2.5 | % |  | 2.6 | % |  | 2.9 | %
Tax benefit related to stock option exercises | (1.1 | %) |  | (3.6 | %) |  | (3.7 | %)
Tax-exempt (gains) losses on corporate-owned life insurance policies | (.6 | %) |  | 2.8 | % |  | (2.9 | %)
Research and development tax credits | (1.9 | %) |  | (1.5 | %) |  | (2.5 | %)
Foreign derived intangible income deduction | (1.9 | %) |  | (1.9 | %) |  | (1.9 | %)
Nondeductible compensation | 1.4 | % |  | 1.2 | % |  | 1.2 | %
Other, net | .6 | % |  | (.2 | %) |  | .7 | %
Effective tax rate | 20.0 | % |  | 20.4 | % |  | 14.8 | %
The Company's effective tax rate decreased to 20.0% in fiscal 2023, down from 20.4% in fiscal 2022. The decrease in the Company's effective tax rate principally reflects a favorable impact from tax-exempt unrealized gains in the cash surrender values of life insurance policies related to the HEICO Leadership Compensation Plan (the "LCP") in fiscal 2023 as compared to tax-exempt unrealized losses recognized in fiscal 2022. This was partially offset by a larger tax benefit from stock option exercises recognized in the first quarter of fiscal 2022 and the portion of acquisition costs associated with fiscal 2023 acquisitions that were not deductible for income tax purposes. The Company recognized a discrete tax benefit from stock option exercises in both the first quarter of fiscal 2023 and 2022 of $6.2 million and $17.8 million, respectively. The Company's effective tax rate was 20.4% in fiscal 2022, as compared to 14.8% in fiscal 2021. The increase in the Company's effective tax rate principally reflects a 5.7% unfavorable impact from tax-exempt unrealized losses in the cash surrender values of life insurance policies related to the LCP recognized in fiscal 2022 as compared to the tax-exempt unrealized gains recognized on such policies in fiscal 2021. The Company files income tax returns in the U.S. federal jurisdiction and in multiple state jurisdictions. The Company is also subject to income taxes in certain jurisdictions outside the U.S., none of which are individually material to the accompanying consolidated financial statements. Generally, the Company is no longer subject to U.S. federal, state or foreign examinations by tax authorities for years prior to fiscal 2019. One of the Company's foreign subsidiaries files income tax returns in The Netherlands and Thailand where the statute of limitations is open for its fiscal 2015 returns. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company believes that it is more likely than not that it will generate sufficient future taxable income to utilize all of its deferred tax assets and has therefore not recorded a valuation allowance on any such asset. Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands):
| As of October 31,
| 2023 |  | 2022
Deferred tax assets: |  |  |
Inventories | $85,560 |  |  | $51,505 |
Deferred compensation plan liability | 44,882 |  |  | 42,285 |
Capitalized research and development costs | 29,142 |  |  | 543 |
Operating lease liabilities | 26,771 |  |  | 20,043 |
Interest expense limitation carryforward | 24,770 |  |  | 24 |
Share-based compensation | 10,665 |  |  | 9,177 |
Performance-based compensation accrual | 6,632 |  |  | 4,482 |
Customer rebates accrual | 4,145 |  |  | 3,323 |
Other | 17,832 |  |  | 17,107 |
Total deferred tax assets | 250,399 |  |  | 148,489 |
Deferred tax liabilities: |  |  |
Goodwill and other intangible assets | (324,774) |  |  | (176,436) |
Property, plant and equipment | (28,533) |  |  | (21,746) |
Operating lease right-of-use assets | (25,620) |  |  | (19,344) |
Other | (3,318) |  |  | (2,125) |
Total deferred tax liabilities | (382,245) |  |  | (219,651) |
Net deferred tax liability | ($131,846) |  |  | ($71,162) |
The increases in the Company's deferred tax assets for inventories and the interest expense limitation carryforward and in the Company's deferred tax liabilities for intangible assets are principally related to such deferred tax assets and liabilities recognized in connection with the fiscal 2023 acquisitions (see Note 2, Acquisitions). Additionally, as a result of the Tax Cuts and Jobs Act, the Company began capitalizing research and development costs beginning in fiscal 2023, which are now amortized over five years for income tax purposes. As of October 31, 2023 and 2022, the Company’s liability for gross unrecognized tax benefits related to uncertain tax positions was $4.4 million and $3.5 million, respectively, of which $3.4 million and $2.8 million, respectively, would decrease the Company’s income tax expense and effective income tax rate if the tax benefits were recognized. A reconciliation of the activity related to the liability for gross unrecognized tax benefits during fiscal 2023 and 2022 is as follows (in thousands):
| Year ended October 31,
| 2023 |  | 2022
Balances as of beginning of year | $3,503 |  |  | $4,072 |
Increases related to current year tax positions | 1,356 |  |  | 870 |
Increases related to prior year tax positions | 214 |  |  | — |
Decreases related to prior year tax positions | — |  |  | (286) |
Settlements | — |  |  | (522) |
Lapses of statutes of limitations | (710) |  |  | (631) |
Balance as of end of year | $4,363 |  |  | $3,503 |

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//740/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration